2003
DOI: 10.1093/jac/dkg127
|View full text |Cite
|
Sign up to set email alerts
|

Mupirocin and Staphylococcus aureus: a recent paradigm of emerging antibiotic resistance

Abstract: We postulate that the steady rise in mupirocin resistance among S. aureus in NZ throughout the 1990s may be due, at least in part, to the over the counter availability of mupirocin from 1991 to 2000. The current patterns of mupirocin consumption need to be reviewed and its use rationalized to maximize the chances of this antibiotic retaining beneficial antistaphylococcal activity.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
96
0
5

Year Published

2004
2004
2016
2016

Publication Types

Select...
7
2
1

Relationship

0
10

Authors

Journals

citations
Cited by 143 publications
(101 citation statements)
references
References 18 publications
0
96
0
5
Order By: Relevance
“…One obvious concern about widespread mupirocin use is the potential for increased drug resistance and subsequent failure [8,15,18,28]. However, selective use of short courses of mupirocin for nasal decolonization is thought not to cause widespread resistance [20].…”
Section: Discussionmentioning
confidence: 99%
“…One obvious concern about widespread mupirocin use is the potential for increased drug resistance and subsequent failure [8,15,18,28]. However, selective use of short courses of mupirocin for nasal decolonization is thought not to cause widespread resistance [20].…”
Section: Discussionmentioning
confidence: 99%
“…Mupirocin Etest (AB Biodisk; MIC range, 0.064 to 1,024 g/ml) was used according to the manufacturer's instructions on Mueller-Hinton agar. The MIC breakpoints were chosen to correlate with previous studies of mupirocin resistance (3,9,14,16,19). Mupirocin susceptibility was defined as an MIC of Ͻ8 g/ml, intermediate resistance as an MIC of 8 to 256 g/ml, and high-level resistance as an MIC of Ն512 g/ml.…”
mentioning
confidence: 99%
“…It is not our routine practice to decolonize patients who are colonized with MRSA, because there is a moderately high rate of mupirocin resistance among S. aureus isolates in New Zealand 6 and there is a lack of evidence for persistent clearance among patients with MRSA colonization at more than 1 site. 7 Until recently, HCWs have been screened for MRSA colonization prior to commencing employment, and those found to be colonized were decolonized before starting work in a clinical care area.…”
Section: Control Of Methicillin-resistantmentioning
confidence: 99%